General
Preferred name
MEGLUMINE
Synonyms
Meglumin,Methylglucamine ()
D(-)-n-methylglucamine ()
NSC-52907 ()
Methylglucamine ()
N-methylsorbitylamine ()
Megluminum ()
NSC-7391 ()
N-Methylglucamine ()
P&D ID
PD002530
CAS
6284-40-8
131133-75-0
Tags
natural product
drug
available
Approved by
FDA
Drug Status
approved
Max Phase
Phase 4
Drug indication
Diagnostic Aid (radiopaque medium)
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
11
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
NPC Screening Collection
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
30
Properties
(calculated by RDKit )
Molecular Weight
195.11
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
6
Rotatable Bonds
6
Ring Count
0
Aromatic Ring Count
0
cLogP
-3.36
TPSA
113.18
Fraction CSP3
1.0
Chiral centers
4.0
Largest ring
0.0
QED
0.26
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
excipient
Source data
